NCT00817479View on ClinicalTrials.gov

Tumor Gene Expression in Women With Ovarian Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Ovarian Cancer
Interventions
DRUG

Dexamethasone

20 MG OF DEXAMETHASONE OR PLACEBO

DRUG

Placebo

Placebo saline

Trial Locations (1)

60637

The University of Chicago, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT00817479 - Tumor Gene Expression in Women With Ovarian Cancer | Biotech Hunter | Biotech Hunter